Amalio Ordóñez, MD | Authors

The UFT/Leucovorin/Etoposide Regimen for the Treatment of Advanced Gastric Cancer

September 02, 1997

Gastric cancer is the most chemosensitive adenocarcinoma among digestive neoplasms. A few years ago, we performed a phase II trial with the FLEP regimen, in which fluorouracil (5-FU) and leucovorin are combined